OPS
KYNB

Orion Portfolio Solutions’s Kyntra Bio KYNB Stock Holding History

Orion Portfolio Solutions’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Hold
0
– – – 2264
2020
Q1 		– Sell
-5
Closed -$4.97K – 2029
2019
Q4 		$5K Buy
+5
New +$5.11K ﹤0.01% 1249

Other funds holding KYNB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Orion Portfolio Solutions's KYNB Position: Q2 2020 in Review

Orion Portfolio Solutions held its Kyntra Bio (KYNB) position steady in Q2 2020 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2264.

Orion Portfolio Solutions first reported a position in KYNB in Q4 2019 and has held it in 1 quarter since. The position peaked at $5K in Q4 2019. 194 funds tracked by Wall St. Rank hold KYNB as of Q2 2020.

  • Orion Portfolio Solutions held 0 shares of Kyntra Bio worth $0 as of Q2 2020.
  • Orion Portfolio Solutions left its Kyntra Bio share count unchanged in Q2 2020.
  • Kyntra Bio made up ﹤0.01% of Orion Portfolio Solutions's portfolio in Q2 2020, its #2264 holding.
  • Orion Portfolio Solutions first reported a position in Kyntra Bio in Q4 2019 and has held it in 1 quarter since.
  • Orion Portfolio Solutions's Kyntra Bio position peaked at $5K in Q4 2019.
  • 194 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2020.

Based on Orion Portfolio Solutions's 13F filing for Q2 2020, filed 13 Aug 2020.